BranchLab

"Pharma brands spend billions of dollars every year on poorly targeted TV advertising. A new startup called BranchLab, which was launched earlier this year by three ad tech vets, wants to change that." Added bonus? BranchLab does it without using IDs, making it one of the most privacy-safe options in market for healthcare advertising. Big thanks to AdExchanger's Alyssa Boyle for diving in with us on our mission and seed funding https://bit.ly/4aSklyA

As the landscape of healthcare advertising evolves, how can brands effectively reach their audiences while ensuring data privacy? Hear from BranchLab’s Mallory Wils at DPE to learn more! https://lnkd.in/e7GXkNpy

Are you struggling to stay ahead of new state privacy regulations? As new laws reshape the landscape, healthcare advertisers need a compliant approach to targeting to ensure advertising effectiveness. BranchLab’s privacy-first solutions go beyond legacy ID-based methods, ensuring compliance in all 50 U.S. states. Get more insights from Mallory Wils interview with Fierce Pharma at #DPE24!

Is your data and targeting solution future-proofed? Or are you still relying on ID-based solutions? Mallory Wils dives into the increase of state privacy regulations, how they are impacting media plans and why an ID-less solution like BranchLab's is the best way to reach HCPs and patients effectively and safely. Check out more insights from Mallory & other industry leaders during a recent MediaPost webinar hosted by our friends at Causal IQ: "Engaging HCP Audiences in the Era of Signal Loss." https://bit.ly/4dofYx6

Is your brand leveraging the full potential of TV data for healthcare marketing? Mallory Wils dives into TV data and how it's emerged as one of the strongest datasets for reaching patients and HCPs. With increased privacy regulations, healthcare and pharma advertisers need to get more diligent and innovative when trying to reach their intended audiences. Thankfully, BranchLab can help. Check out more insights from Mallory & other industry leaders during a recent MediaPost webinar hosted by our friends at Causal IQ: "Engaging HCP Audiences in the Era of Signal Loss." https://bit.ly/4dofYx6

As privacy regulations gain traction across states, pharmaceutical marketers are finding it harder to reach their intended audiences. Having one of the most esteemed legal minds in the pharmaceutical industry join our Board of Advisors makes those challenges a bit easier to navigate for our clients. An official warm welcome to Errol Taylor who joins our board of industry veterans and leaders: Zach Chapman, Andy Fisher, John Harlow, Paul Olliver, Scott Russo, Ari Paparo, Catherine Sullivan Check out the full announcement here: https://lnkd.in/eSEsfaiB

See you in Philly! We’re looking forward to meeting you at #DigitalPharmaEast next month. Head to this link to setup time with our folks on the ground: https://lnkd.in/g5Mnwtr9 #DPE Michael Parkes Mallory Wils Jessica Sheid Christie Hoelting

Thrilled to welcome Errol Taylor to BranchLab's advisory board. Errol's deep expertise in the biopharmaceutical legal landscape will be invaluable as we navigate evolving regulations in healthcare marketing. Increased state privacy regulations are making it more challenging than ever for pharmaceutical companies to reach consumers and HCPs effectively. BranchLab's ID-less approach allows brands to keep connecting with the right audiences while ensuring privacy compliance. And Errol's unparalleled industry acumen will ensure BranchLab stays at the forefront of evolving laws and policies. Read more from Broadcasting & Cable's Jon Lafayette with a deep-dive from both Errol and BranchLab's Co-Founder Michael Parkes https://bit.ly/46Ld5UL

We are opting OUT of using legacy ID infrastructure. Recent regulations are reshaping the landscape and it's time for brands to reconsider how they leverage data and IDs in healthcare advertising. BranchLab believes the answer is ID-less. Check out more insights from Mallory Wils and other industry leaders during a recent MediaPost webinar hosted by our friends at Causal IQ: "Engaging HCP Audiences in the Era of Signal Loss" https://bit.ly/4dofYx6

Is your DTC and HCP strategy in sync? Mallory Wils shares why it's so important for brands to think about how DTC and HCP efforts can work in concert to most effectively drive conversations between doctors and patients. Check out more insights from Mallory and other industry leaders during a recent MediaPost webinar hosted by our friends at Causal IQ: "Engaging HCP Audiences in the Era of Signal Loss" https://bit.ly/4dofYx6